¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen storage disease type V"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
¿µ¹® Wilson's disease ÇÑ±Û Àª½¼º´
¼³¸í   
  °£À̳ª ³ú¿¡ ±¸¸®°¡ ºñÁ¤»óÀûÀ¸·Î ½×¿© ÀϾ´Â À¯Àü¼º ´ë»çº´. °£°æÈ­ÁõÀ̳ª ½Å°æ Áõ»óÀÌ µû¸£´Âµ¥, ¼Õ ¶³¸²À̳ª ¾ð¾î Àå¾Ö°¡ »ý±â°í ´«ÀÇ °¢¸· ÁÖÀ§¿¡ ³ì°¥»ö °í¸®°¡ ³ªÅ¸³­´Ù. ¿µ±¹ÀÇ ½Å°æ°ú ÀÇ»ç Àª½¼(Wilson)ÀÌ ºÐ·ùÇÑ º´ÀÌ´Ù. º¸Åë¿°»öü ¿­¼ºÀ¸·Î À¯ÀüµÈ´Ù. Çѱ¹¿¡¼­µµ ÇöÀç±îÁö 50¿© ¿¹°¡ º¸°íµÇ¾î ÀÖ´Ù. À̺´Àº º¸Åë¿°»öü ¿­¼ºÀ¸·Î À¯ÀüµÇ¸ç, ATP7B¶ó´Â Àª½¼º´ À¯ÀüÀÚ°¡ 13¹ø ¿°»öü¿¡ À§Ä¡ÇÑ´Ù. Æ¯Â¡À¸·Î ±¸¸®°¡ °£, ³ú ¹× °¢¸·¿¡ ÃàÀûÇÏ¿© ¸¸¼º °£¿° ¶Ç´Â °£°æÈ­¿Í °°Àº °£¼Õ»óÀ» ÀÏÀ¸Å°°í, ³ú Æ¯È÷ ·»ÁîÇÙÀÇ ÅðÇà º¯È­¿Í °¢¸·¸ð¼­¸®¿¡ ³ì°¥»öÀÇ Kayser-Fleischer °í¸®¸¦ Çü¼ºÇÑ´Ù. ÀÓ»óÁõ»óÀÇ ¹ßÇöÀº º¸Åë 5~15¼¼¿¡ ½ÃÀÛÇϴµ¥ 30~40¼¼°¡ µÇµµ·Ï Áõ»óÀÌ ¾øÀ» ¼öµµ ÀÖ´Ù.
¿µ¹® hyaline membrane disease ÇÑ±Û À¯¸®Áú¸·º´
¼³¸í   
  ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½Ã۴ ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼­ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼­´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀΠº´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ­, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êȭź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. È¯¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú Ã·´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼­ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈĴ Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־´Â Ä¡·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù.
¿µ¹® fibrocystic disease of breast ÇÑ±Û À¯¹æ ¼¶À¯³¶º´
¼³¸í   
  Á¥À» »ý»êÇϴ Á¥»ù³»¿¡ ¿ÏµÎÄᠶǴ ūÄá Å©±âÀÇ °áÀýÀÌ ¹ß»ýÇϴ Áõ¼¼¸¦ Æ¯Â¡À¸·Î Çϴ º´. 30~50´ëÀÇ ºÎÀο¡°Ô ÈçÈ÷ ¹ß»ýÇϸç, ±× ´ëºÎºÐÀº ¾çÂÊ À¯¹æ¿¡ µ¿½Ã¿¡ ¹ß»ýÇÑ´Ù. ÀÌ·¯ÇÑ °áÀýÀº µÎ ¼Õ°¡¶ô »çÀÌ¿¡ ³¢¿ö ÃËÁøÇÒ ¶§´Â ºÐ¸íÇÏÁö¸¸, È亮À» ¼Õ¹Ù´ÚÀ¸·Î ´©¸£¸é ¸í·áÇÏÁö ¾ÊÀ» Á¤µµ·Î ºÎµå·¯¿î °ÍÀÌ ¸¹´Ù. ±× ¹ß»ý ¿øÀο¡´Â ¿©·¯ °¡Áö ¼³ÀÌ ¸¹Àºµ¥, Á¥»ùÁ¶Á÷¿¡ ´ëÇÑ ¸¸¼ºÀûÀΠÀÚ±ØÀÌ ÁÖ¿øÀÎÀ̶ó »ý°¢µÇ°í ÀÖÀ¸¸ç, ±ØÈ÷ ¼­¼­È÷ ÁøÇàÇϴ °æ°ú¸¦ ¹â´Â´Ù. Áø´ÜÀº ÃËÁø, ÃÊÀ½ÆÄÁø´Ü µîÀ¸·Î Çϸç, ¾Ï°ú °¨º°ÀÌ °ï¶õÇÒ ¶§´Â Á¶Á÷ÀÇ ÀϺθ¦ Ã¤ÃëÇÏ¿© °Ë»çÇϴ »ý°ËÀÌ ÀÌ¿ëµÇ±âµµ ÇÑ´Ù.
¿µ¹® periodontal disease ÇÑ±Û Ä¡ÁÖº´
¼³¸í   
  ÀÕ¸ö°ú Ä¡¾Æ, ±×¸®°í ±× ÁÖÀ§ »ÀÀÇ ¿°Áõ°ú ÅðÇ༺ º¯È­¸¦ ¸»ÇÔ. Ä¡·á¿¡ À־ ÀÕ¸öÀÇ Á¦°Å°¡ ÇʼöÀûÀÌ´Ù. ÀÕ¸öÀÇ Á¦°Å´Â »õ·Î¿î ÀÕ¸öÀÇ »ý¼ºÀ» Á¶ÀåÇÑ´Ù.
¿µ¹® Crohn's disease ÇÑ±Û Å©·Ðº´
¼³¸í   
  ¸¸¼ºÀûÀ̰í Àç¹ßÀ» ÀßÇϴ âÀÚÀÇ ¿°ÁõÀ» Æ¯Â¡À¸·Î Çϴ º´. ÀåÀÇ º®Àº ¾ÈÂÊ¿¡¼­ºÎÅÍ Á¡¸·, Á¡¸·ÇÏÁ¶Á÷, ±ÙÀ°Ãþ, À帷ÀÇ 4°³ÀÇ ÃþÀ¸·Î ÀÌ·ç¾îÁ® Àִµ¥, Å©·Ðº´Àº ÀÌ ¸ðµç ÃþÀÇ ¿°ÁõÀ» µ¿¹ÝÇÑ´Ù. ÀåÀÇ ¸ðµç ºÎºÐ¿¡¼­ »ý±æ ¼ö°¡ ÀÖÁö¸¸ ÁַΠ¸·Ã¢ÀÚ¿Í ¿¬°áµÇ´Â Å«Ã¢ÀÚÀÇ ¸»´ÜºÎ¿¡ °¡Àå ¸¹ÀÌ »ý±ä´Ù. Ã¢ÀÚÀÇ ÀüÃþÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ÀåÀÇ Æó¼â³ª ±«¾çÀ» ¸¸µé¸ç Á¾Á¾ Ãµ°øµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • arteriosclerotic cardiovascular disease
    µ¿¸Æ°æÈ­½É(Àå)Ç÷°üº´
  • arteriosclerotic heart disease
    µ¿¸Æ°æÈ­½ÉÀ庴
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½ºº´
  • autoallergic disease
    ÀÚ°¡¾Ë·¹¸£±âº´
  • autoimmune disease
    ÀÚ°¡¸é¿ªÁúȯ
  • autoimmune inner ear disease
    ÀÚ°¡¸é¿ª¼Ó±Íº´, ÀÚ°¡¸é¿ª³»ÀÌÁúȯ
  • aviator¡¯s disease
    ºñÇà»çº´
  • acquired cystic kidney disease
    ÈÄõ³¶¼ºÄáÆÏº´, ÈÄõ³¶¼º½ÅÀ庴
  • Addison¡¯s disease
    ¾Öµð½¼º´
  • adult disease
    ¼ºÀκ´
  • Albers-Schonberg disease
    ¾Ëº£¸£½º-¼éº£¸£Å©º´
  • Alexander disease
    ¾Ë·º»ê´õº´
  • alkali disease
    ¾ËÄ®¸®º´
  • allergic disease
    ¾Ë·¹¸£±âº´
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pyknic body type
    ºñ¸¸½ÅüÇü
  • split-electrode-type probe
    ºÐÇÒÀü±Ø´õµëÀÚ
  • scirrhous type
    °æÈ­Çü
  • simple type schizophrenia
    ´Ü¼øÁ¤½ÅºÐ¿­º´
  • sthenic type
    ±Ù·ÂÇü
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü
  • type species
    Ç¥ÁرÕÁ¾
  • type specificity
    ÇüƯÀ̼º
  • type specimen
    ±âÁØÇ¥º»
  • type strain
    Ç¥ÁرÕÁÖ
  • type
    Çü, À¯Çü
  • test type
    ½Ã°¢Ç¥, ½ÃÇ¥
  • accumulation disease
    ÃàÀûº´
  • acquired cystic kidney disease
    ÈÄõ³¶¼ºÄáÆÏº´
  • acute infectious disease
    ±Þ¼º°¨¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hyperlipoproteinemia type IV
    °í´Ü¹éÇ÷Áõ IV Çü
  • hyperlipoprotenemia type II
    °íÁö´Ü¹éÇ÷Áõ II Çü
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
  • hypertrophic type
    ºñ´ëÇü
  • hypogammaglobulinemia, Swiss-type
    ½ºÀ§½ºÇü °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • personality disorder, mixed type
    È¥ÀçÇü(ûèî¤úþ) ÀΰÝÀå¾Ö
  • personality, type A
    AÇü ÀΰÝ
  • personality, type B
    BÇü ÀΰÝ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • calcified hypertrophic type
    ¼®È¸È­ºñ´ëÇü
  • catatonic type
    ±äÀåÇü
  • cellular type dermatofibroma
    ¼¼Æ÷Çü ÇǺμ¶À¯Á¾
  • chief cell type i glomus cell
    °ú¸³¼¼Æ÷
  • cryptogenic type
    ÀáÀçÇü(ËöËøÌ´).
  • cryptogenic type
    ÀáÀçÇü(íÖî¤úþ).
  • crystal type
    °áÁ¤Çü
  • culture, type
    Ç¥ÁرÕÁÖ, ±âÁØÁÖ
  • cyclicodevelopmental type
    ÁÖ±âÀû ¹ßÀ°Çü(ÊÙËÑËôÌ´).
  • cyclicopropagative type
    ÁÖ±âÀû Áõ½ÄÇü(ÊÙÌ¡ËàÌ´).
  • delayed type hypersensitivity
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • demand type pacemaker
    ¼ö¿äÇü½É¹ÚÁ¶À²±â.
  • demblee type mycosis fungoides
    Àü°ÝÇü±Õ»ó½ÄÀ°Á¾
  • dementia of Alzheimers type
    ¾ËÃ÷ÇÏÀ̸ÓÇü Ä¡¸Å(~û¡ ö¸Å)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
  • Krabbe's disease
    Å©¶óº£Áúȯ(òðü´)
  • Kwok's disease
    °û Áúȯ(òðü´)
  • lysosomal disease
    ¶óÀ̼ÒÁ»Áúȯ(òðü´)
  • maple syrup urine disease
    ´Üdz½Ã·´´¢Áúȯ(Òãòðü´)
  • metabolic disease
    ´ë»çÁúȯ(ÓÛÞóòðü´)
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»)
  • Niemann-Pick disease
    ´Ï¸¸-ÇÈ Áúȯ(òðü´)
  • Parkinson's disease
    ÆÄŲ¼Õ º´(Ü»)
  • Pompe's disease
    ÆûÆä Áúȯ(òðü´)
  • Refsum's disease
    ·¾¼û Áúȯ(òðü´)
  • Sandhoff's disease
    ¼¾µµÇÁ Áúȯ(òðü´)
  • sickle cell disease
    ³´¼¼Æ÷(á¬øà)Áúȯ(òðü´)
  • Tangier disease
    źÁö¿¡¸£ Áúȯ(òðü´)
  • Tay-Sachs disease
    ŸÀÌ-»è½º Áúȯ(òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • polycystic disease
    ´Ù³¶¼ºÁúȯ
  • professional disease
    Àü¹®Á÷º´, Á÷¾÷º´
  • pulseless disease
    ¹«¸Æº´, ´ÙÄ«¾ß½ºº´
  • respiratory disease
    È£Èí±âº´, È£Èí°ï¶õ
  • restrictive heart disease
    ±¸¼Ó¼º½ÉÁúȯ
  • restrictive lung disease
    ±¸¼Ó¼ºÆóÁúȯ
  • restrictive pulmonary disease
    ±¸¼Ó¼ºÆóÁúȯ
  • rheumatic disease
    ·ù¸¶Æ¼½º¼ºÁúȯ
  • rheumatic heart disease
    ·ù¸¶Æ¼½º¼º½ÉÁúȯ
  • spirochetal disease
    ½ºÇÇ·ÎÇìŸÁúȯ
  • Tay-Sachs disease
    Å×ÀÌ-»è½ºº´
  • thromboembolic disease
    Ç÷Àü»öÀü¼ºÁúȯ
  • Tietzes disease+B701
    ƼÂź´
  • underlying disease
    ¿øÁúȯ, ±âÃÊÁúȯ
  • valvular disease
    ÆÇ¸·Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CESD cholesterol ester storage disease
INLSD ichthyosis and neutral lipid storage disease
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
ARD absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira...
DD dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
Type 1 type
type I type B
CMT1 Charcot--Marie--Tooth disease type 1
CMT1A Charcot-Marie Tooth disease type 1A
MDV1 Marek's disease virus type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • schizoid type
    ºÐ¿­Çü
  • schizophrenia of childhood type
    ¾Æµ¿Çü Á¤½Å ºÐ¿­Áõ
    »çÃá±â¿¡ ¹ßº´ÇÏ´Â Á¤½Å ºÐ¿­ÁõÀ¸·Î¼­ ÀÚÆó¼º, ³»Ç⼺, ºñÁ¤ÇüÀû ÇൿÀ» Ư¡À¸·Î ÇÑ´Ù.
  • screen-type cassette
    ½ºÅ©¸°Çü Ä«¼¼Æ®
    ´ë°Ô ±Ý¼ÓÀ¸·Î ¸¸µé¾î Á³À¸¸ç, ³ëÃâ¸éÀº º£ÀÌŬ¶óÀÌÆ®, ¾Ë·ç¹Ì´½, ¸¶±×³×½·°ú °°Àº ³·Àº ¿øÀÚ ¹øÈ£ÀÇ ¹°Áú·Î µÇ¾î ÀÖ°í, Áõ°¨Áö¸¦ Æ÷ÇÔÇϰí À־ ±× »çÀÌ¿¡ X-¼± ³ëÃâÀ» À§ÇÑ "½ºÅ©¸°Çü" Çʸ§À» À§Ä¡½ÃŲ´Ù.
  • spaced type of deciduous dentition
    À¯±ØÇü À¯Ä¡¿­±Ã
  • spindle cell type
    ¹æÃß ¼¼Æ÷Çü
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • sympathicotonic type
    ±³°¨½Å°æ ±äÀåÇü
  • target type
    ¸ñÇ¥¹° ÇüÅÂ
  • type A personality
    AÇü Àμº
  • type B personality
    BÇü Àμº
  • type cultural
    ´ëÇ¥ ±ÕÁ¾ ¹è¾ç, Ç¥ÁØ ¹è¾ç
  • type II
    2Çü
  • type III
    3Çü
  • type of eruption
    ¸ÍÃâÇü
  • type strain
    ´ëÇ¥ ±ÕÁ¾, Ç¥ÁØ ±ÕÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
viral hepatitis type A A virus disease with a short incubation period (usually 15 to 50 days), caused by hepatitis A virus, a member of the family Picornaviridae, often transmitted by faecal-oral route; may be inapparent, mild, severe, or occasionally fatal and occurs sporadically or in epidemics, commonly in school-age children and young adults; necrosis of periportal liver cells with lymphocytic and plasma cell infiltration is characteristic and jaundice is a common symptom.
Synonym: epidemic hepatitis, hepatitis A, infectious hepatitis, MS-1 hepatitis, short incubation hepatitis, virus A hepatitis.
(05 Mar 2000)
viral hepatitis type B A virus disease with a long incubation period (usually 50 to 160 days), caused by hepatitis B virus, a DNA virus and member of the family Hepadnoviridae, usually transmitted by injection of infected blood or blood derivatives or by use of contaminated needles, lancets, or other instruments; clinically and pathologically similar to viral hepatitis type A, but there is no cross-protective immunity; HBsAg is found in the serum and the hepatitis delta virus occurs in some patients.
Synonym: hepatitis B, serum hepatitis, transfusion hepatitis, virus B hepatitis.
(05 Mar 2000)
viral hepatitis type C Principal cause of non-A, non-B posttransfusion hepatitis caused by an RNA virus that may be related to Flaviviridae family.
Synonym: hepatitis C, virus C hepatitis.
(05 Mar 2000)
viral hepatitis type D Acute or chronic hepatitis caused by the hepatitis delta virus, a defective RNA virus requiring HBV for replication. The acute type occurs in two forms: 1) coinfection, the simultaneous occurrence of hepatitis B virus and hepatitis delta virus infections, which usually is self-limiting; 2) superinfection, the appearance of hepatitis delta virus infection in a hepatitis B virus carrier, which often leads to chronic hepatitis The chronic type appears to be more severe than other types of viral hepatitis.
Synonym: delta hepatitis, hepatitis D.
(05 Mar 2000)
viral hepatitis type E Hepatitis caused by a nonenveloped, single-stranded, positive-sense RNA virus 27-34 nm in diameter, unrelated to other hepatitis; it is the principal cause of enterically transmitted, waterborne, epidemic NANB hepatitis occurring primarily in Asia and Africa.
Synonym: hepatitis E.
(05 Mar 2000)
central type neurofibromatosis Type I neurofibromatosis.
Incomplete neurofibromatosis, multiple neurofibromas with minimal manifestations, perhaps limited to cafe-au-lait spots; individuals with minimal lesions may have offspring with severe involvement.
Synonym: abortive neurofibromatosis.
(05 Mar 2000)
V-type ATPase <enzyme> From eukaryotic endomembrane systems, including vacuoles, lysosomes, golgi apparatus, chromaffin granules and coated vesicles. One of three major classes of ion transport ATPase, characterised by a multi subunit structure and a lack of a phosphorylated intermediate.
Found in archaebacteria but not eubacteria, in the intracellular acidic vacuoles and in some proton pumping epithelia (e.g. Intercalated cells of kidney). A complex enzyme encoded by several genes, involved in ion translocation but does not act via phosphorylated enzyme intermediate
See: P-type ATPase.
Registry number: EC 3.6.1.-
Synonym: atpase, v-type, atpase, vacuolar, vacuolar atpase, v-atpase, vacuolar h+-atpase, vacuolar membrane h(+)-atpase, vha55 gene product, vma16 gene product
(26 Jun 1999)
Gm type <immunology> Genetically determined allotypic antigens found on IgG of some individuals.
(18 Nov 1997)
Golgi type II neuron <physiology> Nerve cells with short axons which ramify in the gray matter.
(05 Mar 2000)
Golgi type I neuron <physiology> Nerve cells whose long axons leave the gray matter of which they form a part.
(05 Mar 2000)
membrane-type 3 matrix metalloproteinase <enzyme> Sm3 is a soluble form of mt3-mmp, probably an alternatively sliced variant.
Registry number: EC 3.4.24.-
Synonym: mt3-mmp, sm3-mmp
(26 Jun 1999)
membrane-type 4 matrix metalloproteinase <enzyme> Cloned from breast carcinoma.
Registry number: EC 3.4.24.-
Synonym: mt4-mmp, mmp-17 gene product, mmp-17
(26 Jun 1999)
membrane-type matrix metalloproteinase <enzyme> Activates gelatinase a; isolated from a human placenta cdna gene library; contains a transmembrane domain; do not use for any other numbered matrix metalloproteinases; genbank d26512
Registry number: EC 3.4.24.-
Synonym: mt-mmp, mmp-x1 protein, matrix metalloproteinase, membrane-type, mmp14 gene product, mmp-14 gene product, mt1-mmp, matrix metalloproteinase 14, mt2-mmp, mmp15 gene product, mmp16 gene product
(26 Jun 1999)
retroviruses type b, mammalian A genus of the family retroviridae consisting of a few exogenous, vertically transmitted and endogenous viruses of mice. It is associated with mammary carcinoma and T-cell lymphoma.
(12 Dec 1998)
retroviruses type c, avian A genus of the family retroviridae with type c morphology, that causes malignant and other diseases in wild birds and domestic fowl.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • footinmouth disease
    ½Ç¾ðº®
  • green monkey disease
    =MARBURG DISEASE
  • heart disease
    ½ÉÀ庴
  • heart disease
    ½ÉÀ庴
  • hoof and mouth disease
    =FOOT AND MOUTH DISEASE
  • industrial disease
    (ÀÇ)Á÷¾÷º´
  • kashinBeck disease
    ij½Åº¤º´(À½·á¼ö ÁßÀÇ À¯±â»ê¿¡ ÀÇÇÑ »ÀÀÇ º¯Çü)
  • kissing disease
    Àü¿°¼º ´ÜÇÙÁõ;Ű½º º´
  • molecular disease
    ºÐÀÚº´
  • mosaic disease
    ¸ðÀÚÀÌÅ© º´(½Ä¹°ÀÇ Àü¿°º´)
  • occupational disease
    Á÷¾÷º´
  • parkinsons disease
    ÁøÀü ¸¶ºñ
  • pind disease
    Áö´Üµ¿ÅëÁõ(À¯¾Æº´)
  • pink disease
    Áö´Üµ¿Åë
  • pompe's disease
    ÆûÆäº´
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á